Noteworthy Scios joins players in quest for fat fighter

The obesity story is getting interestinger and interestinger, as Alice might have said in Wonderland, with Scios Nova Inc. being the potential beneficiary of the latest scientific revelation. The new piece of the puzzle was reported last week in Nature by researchers at Hammersmith Hospital in London.

According to that report, GLP-1, a peptide found in the hypothalamus, is an important physiological mediator of satiety and may be the most potent inhibitor of feeding yet identified in rats.